Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROGEN CORP | 13,571,411 | reported | 25 Jul 2008 | tx 18+5,435,096−192,307 |
| INTERMUNE INC | 77,251 | reported | 28 Feb 2013 | tx 38+5,335,886−9,515,836 |
| Larimar Therapeutics, Inc. | 55,150 | reported | 19 May 2026 | tx 7+134,650 |
| Hana Biosciences Inc | 35,000 | reported | 17 Feb 2012 | tx 6+220,308 |
| AveXis, Inc. | 18,111 | reported | 10 Feb 2016 | tx 2+26,496 |
| BiomX Inc. | 17,600 | reported | 14 Apr 2025 | tx 3+281,600−17,600 |
| Protara Therapeutics, Inc. | 12,700 | reported | 08 Jun 2018 | tx 2+26,033 |
| SUNESIS PHARMACEUTICALS INC | 10,000 | reported | 05 Jun 2008 | tx 7+1,753,909 |
| Altus Pharmaceuticals Inc. | 8,722 | reported | 12 Jun 2008 | tx 7+3,615,480−4,307,163 |
| Nivalis Therapeutics, Inc. | 7,650 | reported | 11 Sept 2015 | tx 2+19,125 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 14 Apr 2025 | GRANT_AWARD | BiomX Inc. | 17,600 | 0.00 USD | deriv |
| 11 Jul 2024 | GRANT_AWARD | BiomX Inc. | 264,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 09 May 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 10 May 2022 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 29 Sept 2020 | GRANT_AWARD | Larimar Therapeutics, Inc. | 16,600 | 0.00 USD | deriv |
| 08 Jun 2018 | GRANT_AWARD | Protara Therapeutics, Inc. | 12,700 | 0.00 USD | deriv |
| 02 Aug 2017 | GRANT_AWARD | Protara Therapeutics, Inc. | 13,333 | 0.00 USD | deriv |
| 10 Feb 2016 | GRANT_AWARD | AveXis, Inc. | 8,385 | 0.00 USD | deriv |
| 10 Feb 2016 | GRANT_AWARD | AveXis, Inc. | 18,111 | 0.00 USD | deriv |
| 11 Sept 2015 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 7,650 | 0.00 USD | deriv |
| 16 Jul 2015 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 11,475 | — | deriv |
| 28 Feb 2013 | TAX_WITHHOLDING | INTERMUNE INC | 7,108 | 8.79 USD | |
| 04 Sept 2012 | TENDER | ALLOS THERAPEUTICS INC | 55,000 | 1.82 USD | |
| 04 Jun 2012 | GRANT_AWARD | INTERMUNE INC | 2,500 | 10.10 USD | |
| 04 Jun 2012 | GRANT_AWARD | INTERMUNE INC | 6,000 | 0.00 USD | deriv |
| 17 Feb 2012 | GRANT_AWARD | Hana Biosciences Inc | 35,000 | 0.00 USD | deriv |
| 09 Jan 2012 | GRANT_AWARD | Hana Biosciences Inc | 99,000 | 100.00 USD | deriv |
| 09 Jan 2012 | GRANT_AWARD | Hana Biosciences Inc | 1 | — | deriv |
| 13 Dec 2011 | GRANT_AWARD | ALLOS THERAPEUTICS INC | 55,000 | 0.00 USD | |
| 21 Jun 2011 | GRANT_AWARD | ALLOS THERAPEUTICS INC | 20,000 | 2.06 USD | deriv |
| 07 Jun 2011 | OTHER | INTERMUNE INC | 18,718 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 10 Aug 2009.